Stocks Most Actives - Yahoo Finance
- PFEReuters•2 hours ago
Trump presidency could prove a salve for pharma merger deals
Biotechnology companies, whose U.S. shares soared Wednesday after Republican Donald Trump's presidential election, may soon see another benefit: an uptick in biotech M&A. A potential influx of foreign cash and improved stock valuations under the Trump administration would likely boost dealmaking in the industry, which has been anemic ever since political rhetoric against high drug prices picked up late last year, industry analysts and investment bankers said. It could also throw a lifeline to smaller biotech firms, which on average have only 11 months of cash left to finance their research, according to Thomson Reuters data, and have been hesitant to try to raise money during a weak equities market.
- FBFinancial Times•3 hours ago
[$$] Zuckerberg denies that fake news on Facebook influenced US vote
Mark Zuckerberg, Facebook founder and chief executive, has shot down allegations that fake news spread on the social network influenced the US presidential election. Fake news stories were a "very ...